Squarepoint’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Buy
571,930
+242,714
+74% +$886K ﹤0.01% 2267
2026
Q1
$1.3M Buy
329,216
+148,400
+82% +$747K ﹤0.01% 2553
2025
Q4
$1.22M Buy
180,816
+119,515
+195% +$838K ﹤0.01% 2437
2025
Q3
$428K Sell
61,301
-5,205
-8% -$36.2K ﹤0.01% 3379
2025
Q2
$406K Buy
66,506
+32,800
+97% +$218K ﹤0.01% 3443
2025
Q1
$256K Sell
33,706
-4,815
-12% -$40.2K ﹤0.01% 3852
2024
Q4
$371K Sell
38,521
-76,385
-66% -$595K ﹤0.01% 3995
2024
Q3
$679K Buy
114,906
+91,015
+381% +$603K ﹤0.01% 2890
2024
Q2
$166K Sell
23,891
-40,144
-63% -$282K ﹤0.01% 3705
2024
Q1
$493K Sell
64,035
-117,149
-65% -$942K ﹤0.01% 3050
2023
Q4
$1.59M Buy
181,184
+101,098
+126% +$740K ﹤0.01% 2174
2023
Q3
$584K Sell
80,086
-53,636
-40% -$400K ﹤0.01% 2676
2023
Q2
$884K Buy
+133,722
New +$682K ﹤0.01% 2257
2023
Q1
Sell
-10,240
Closed -$28.5K 3553
2022
Q4
$28.5K Buy
+10,240
New +$30.6K ﹤0.01% 3094
2021
Q4
Sell
-26,365
Closed -$160K 3393
2021
Q3
$160K Buy
+26,365
New +$297K ﹤0.01% 2572
2021
Q2
Sell
-48,683
Closed -$501K 3508
2021
Q1
$501K Buy
+48,683
New +$470K ﹤0.01% 2016
2018
Q3
Sell
-183,339
Closed -$1.17M 2116
2018
Q2
$1.17M Sell
183,339
-218,636
-54% -$1.56M 0.02% 830
2018
Q1
$2.8M Buy
401,975
+260,826
+185% +$3.04M 0.04% 463
2017
Q4
$1.78M Buy
141,149
+5,499
+4% +$67.1K 0.03% 602
2017
Q3
$1.61M Buy
+135,650
New +$2.01M 0.03% 570
2017
Q1
Sell
-13,895
Closed -$123K 1746
2016
Q4
$123K Buy
+13,895
New +$125K 0.01% 1586
2016
Q2
Sell
-31,600
Closed -$276K 1253
2016
Q1
$276K Buy
+31,600
New +$263K 0.02% 859
2015
Q4
Sell
-29,909
Closed -$289K 1282
2015
Q3
$289K Buy
+29,909
New +$316K 0.07% 281

Other funds holding MDXG

Squarepoint's MDXG Position: Q2 2026 in Review

Squarepoint increased its MiMedx Group (MDXG) stake by 74% in Q2 2026, buying an estimated $886K and bringing the position to 571,930 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

Squarepoint first reported a position in MDXG in Q3 2015 and has held it in 23 quarters since. The position peaked at $2.8M in Q1 2018. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Squarepoint held 571,930 shares of MiMedx Group worth $2.2M as of Q2 2026.
  • Squarepoint bought 242,714 MiMedx Group shares in Q2 2026, an estimated $886K.
  • MiMedx Group made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2267 holding.
  • Squarepoint first reported a position in MiMedx Group in Q3 2015 and has held it in 23 quarters since.
  • Squarepoint's MiMedx Group position peaked at $2.8M in Q1 2018.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.